SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB: INNV), today announced full year 2016 net revenues of $4.8 million compared to $0.7 million in revenues for the same period in 2015 and fourth quarter of 2016 net revenues of $1.7 million compared to $0.2 million in revenues for the same period in 2015.
“We believe our revenue growth for all of 2016 highlights the strength of our Beyond Human® Sales and Marketing platform that we acquired in March 2016 along with the high value products we are commercializing,” stated Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. “Looking forward to 2017, we continue to be focused on increasing annual revenues to $15 million by executing on our goals of expanding our product lines and making our products commercially available in the United States and outside of the United States through our partners, and achieving profitability.”
